For the growing number of multi-indication medicines, challenges arise in assessing and paying for value across medicine indications with a uniform price (see our previous report and further ...
The National Institute for Health and Care Excellence (NICE)’s severity modifier assigns greater weight to health gains to patients with more severe diseases, making it more likely that treatments for ...
Dilek is a senior health policy expert who has held various positions including Deputy General Manager at the Social Security Institution of Türkiye. She holds a master’s degree in International ...
This blog by Martina Garau (OHE) and Dr. Tina Wang (CIRS) provides a framework to navigate key aims, challenges and opportunities offered by recent initiatives and reflects on future prospects.
Siva is chief analyst in the policy team, leading on projects covering NHS funding, finances, productivity and performance. Before joining the Fund in 2017, Siva was head of analysis at NHS Providers ...
Sarin KC is the Head of the Environmental Economics Unit at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand. As a health economist, he has ...
Anthony (Tony) Culyer, CBE, BA, Hon DEcon, Hon FRCP, FRSA, FMedSci, is a professor emeritus in the Department. He has spent his career since 1969 at York. He is also a senior research fellow at the ...
Ting (Tina) Wang is Associate Director, HTA Programme and Strategic Partnerships at the Centre for Innovation in Regulatory Science (CIRS). Tina leads CIRS’ work on HTA strategy and research as part ...